Citation

Aylin Yilmaz, Magnus Gisslen, M.D., Ph.D., Serena S. Spudich, M.D., Evelyn Lee, Anura L. Jayewardene, Ph.D., Francesca Aweeka, Pharm.D., Richard W. Price, M.D. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. Public Library of Science One. 2009 Sep 01; 4(9):e6877 1-5. PMCID: PMC2731205.

Citation

Yvonne J. Bryson, M.D., Mark Mirochnick, M.D., Alice M. Stek, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James D. Connor, M.D., Edmund Capparelli, Pharm.D., Heather D. Watts, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Bethann Cunningham, B.S., Lynette Purdue, Pharm.D., Yetemegnu Asfaw, B.S., Margaret A. Keller, M.D., Elizabeth (Betsy) Smith, M.D. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women. HIV Clinical Trials. 2009 Feb 17; 9(2):115-25. PMID: 18474496.

Citation

Jennifer R. King, Pharm.D., Edward P. Acosta, Pharm.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., Bobbie L. Graham, B.S., Vincent J. Carey, Ph.D., Paula Britto, M.S. Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients. Pediatric Infectious Disease Journal. 2009 Feb 01; 28(2):159-161. PMID: 19106779; PMCID: PMC2755569.

Citation

Patricia A. Garvie, Ph.D., Joanne Lawford, Ph.D., Patricia M. Flynn, M.D., M.S., Aditya Gaur, M.D., Marvin Eric Belzer, M.D., George D. McSherry, M.D., Lawrence B. Friedman, M.D., ChengCheng Hu, Ph.D. Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability. Journal of Adolescent Health. 2009 Feb 01; 44(2):124-32. PMID: 19167660; PMCID: PMC2659610.

Citation

Sylvie Naar-King, M.D., Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., John J. Farley, M.D., M.P.H., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Kathleen Malee, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D. Allocation of family responsibility for illness management in pediatric HIV. Journal of Pediatrics. 2009 Mar 01; 34(2):187-94. PMID: 18586756; PMCID: PMC2722122.

Citation

Anne Butler, M.S., Paige L. Williams, Ph.D., Lois C. Howland, M.S., M.P.H., D.Ph., Deborah S. Storm, R.N.,Ph.D, Nancy Hutton, M.D., George Seage, III, Sc.D., M.P.H. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics. 2009 Mar 11; 123(3):935-43. PMID: 19255023; PMCID: PMC2697844.

Citation

Grace M. Aldrovandi, MD, Jane C. Lindsey, Sc.D., Denise L. Jacobson, Amanda Zadzilka, B.S., Elizabeth Sheeran, M.S., R.D., John ( Jack ) Moye, Jr., M.D., Peggy R. Borum, Ph.D., William A. Meyer, III, Ph.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D. Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team. AIDS. 2009 Mar 27; 23(6):661-72. PMID: 19279441; PMCID: PMC2680185.

Citation

Thomas Valente, Ph.D., Jennifer B. Zogg, Ph.D., Jean Richardson, Ph.D., Andrea Kovacs, M.D., Eva A. Operskalski, Ph.D., M.B.A. Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort. Journal of Acquired Immune Deficiency Syndromes. 2009 Dec 01; 52(4):514-23. PMID: 19584741; PMCID: PMC2783777.

Citation

John W. Sleasman, M.D., Brian Robbins, Ph.D., Shane Cross, Pharm.D., Jane C. Lindsey, Sc.D., Barbara E. Heckman, B.S., H.G. Sprenger, M.D., Nancy Tustin, M.L.T., (ASCP), Charles Rose, Gary E. Pakes, Pharm.D., Edmund Capparelli, Pharm.D., P Poston, E Neal, M Nikanjam. Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults. Clinical Pharmacology & Therapeutics. 2009 Apr 01; 85(4):394-401. PMID: 19118380; PMCID: PMC2767189.